Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Durham, North Carolina


The purpose of this study is to determine if duloxetine is effective when compared to placebo in preventing recurrence of major depressive disorder in patients who have responded to open-label duloxetine treatment.


Inclusion Criteria: - Signed the informed consent - Meet criteria for major depressive disorder without psychotic features. - Have a level of understanding sufficient to provide informed consent and to communicate with the investigator and site personnel. - Have had at least one other major depressive episode prior to the one being experienced at study entry. - You are reliable and agree to keep all appointments for clinic visits, tests and procedures required by the protocol. Exclusion Criteria: - You have had treatment with a drug within the last 30 days that has not received regulatory approval at the time of study entry. - Any women who are pregnant or breast feeding. - If you have any serious medical illnesses other than major depressive disorder. - If you have previously participated in a clinical trial for duloxetine. - Any previous or current diagnosis of bipolar, schizophrenia, or other psychotic disorders.



Primary Contact:


Backup Contact:


Location Contact:

Durham, North Carolina
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.